| 000 | 01627 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516070452.0 | ||
| 264 | 0 | _c20120529 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-011-0085-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Jen-Tsun | |
| 245 | 0 | 0 |
_aChemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer. _h[electronic resource] |
| 260 |
_bAdvances in therapy _cJan 2012 |
||
| 300 |
_a71-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Metastasis _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 700 | 1 | _aLai, Guam-Min | |
| 700 | 1 | _aChang, Tung-Hao | |
| 700 | 1 | _aLiu, Mu-Tai | |
| 700 | 1 | _aBi, Chu-Ping | |
| 700 | 1 | _aWang, Jer-Wei | |
| 700 | 1 | _aChen, Mu-Kuan | |
| 773 | 0 |
_tAdvances in therapy _gvol. 29 _gno. 1 _gp. 71-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-011-0085-2 _zAvailable from publisher's website |
| 999 |
_c21384194 _d21384194 |
||